Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2014

Feb 14, 2014

30237_dirs_2014-02-14_760c89c8-a2a6-4478-bba2-368bbd196b03.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2014-02-12

Reporting Person: Boyle James T. Jr. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-12 Common Stock M 2836 Acquired 31024 Direct
2014-02-12 Common Stock F 941 $90.98 Disposed 30083 Direct
2014-02-12 Common Stock M 3333 Acquired 33416 Direct
2014-02-12 Common Stock F 1105 $90.98 Disposed 32311 Direct
2014-02-13 Common Stock S 1895 $90.29 Disposed 30416 Direct
2014-02-13 Common Stock S 2228 $90.29 Disposed 28188 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-12 Restricted Stock Unit $ M 2836 Disposed Common Stock (2836) Direct
2014-02-12 Restricted Stock Unit $ M 3333 Disposed Common Stock (3333) Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax and withholding obligations.

F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2014.